title: Current Concepts on Diabetic Nephropathy and 2014 Data on Diabetic Renal Failure in Texas.
abstract: Diabetic nephropathy (DN) is the leading cause of end-stage renal disease (ESRD) in the United States and other developed countries. In 1982, diabetes accounted for 27% of patients with ESRD in the United States and rose to 36% by 1992 and to 47% in 2012. Currently, the number of prevalent cases of ESRD in the country (dialysis and transplant) exceeds more than 636,900. Primary care practitioners (PCP) provide more than 90% of the diabetic care and are well-positioned to identify, prevent, and treat initially DN. PCPs should identify DN with a urine microalbumin test, obtain a serum creatinine and glomerular filtration rate, monitor hemoglobin A1c, and treat hypertension and dyslipidemia according to current guidelines. This article reviews basic concepts and goals for DN as well as the 2014 data for diabetic renal failure in the most populous counties in Texas. The Texas counties bordering Mexico show an excessive prevalence of diabetic renal failure.
authors.forename: Patricio A
authors.initials: PA
authors.lastname: Pazmino
mesh_terms: D003928:Diabetic Nephropathies / Q000175:diagnosis* / Q000453:epidemiology / Q000503:physiopathology / Q000517:prevention & control; D018450:Disease Progression; D006801:Humans; D007676:Kidney Failure, Chronic / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology / Q000517:prevention & control; D007677:Kidney Function Tests; D009765:Obesity / Q000150:complications* / Q000503:physiopathology / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D015995:Prevalence; D012307:Risk Factors; D013781:Texas / Q000453:epidemiology